Get started
Author

Еремеева Анна Викторовна

Observed names: A. Eremeeva, A. V. Eremeeva, A.V. Eremeeva, Anna Eremeeva, Anna V. Eremeeva, А. В. Еремеева, Еремеева А. В., Еремеева А.В.
Institution: BIOCAD (Russia)
ORCID: 0000-0001-5196-6911
Observed ORCID: 0000-0001-5196-6911
OpenAlex ID: A5016536735
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study
2021 · Nikita V. Lomakin, Bulat A. Bakirov, et al. · Inflammation Research · 58
PDF
Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS
2023 · A.N. Boyko, V.M. Alifirova, et al. · S S Korsakov Journal of Neurology and Psychiatry · 14
Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS
2024 · A.N. Boyko, V.M. Alifirova, et al. · S S Korsakov Journal of Neurology and Psychiatry · 13
PDF
Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study
2022 · Vadim I. Mazurov, Tatiana V. Dubinina, et al. · Clinical and Experimental Rheumatology · 13
Long-term efficacy and safety of netakimab in patients with active ankylosing spondylitis: results of three years of use in the international multicentre, randomized, double-blind, phase III clinical trial BCD-085-5/ASTERA
2024 · V. I. Mazurov, Sh. F. Erdes, et al. · Modern Rheumatology Journal · 9
PDF
Netakimab for the treatment of psoriatic arthritis: 3-year results of the phase III BCD-085-8/PATERA study
2024 · T. V. Korotaeva, V. I. Mazurov, et al. · Modern Rheumatology Journal · 7
PDF
Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR
2023 · V. I. Mazurov, A. M. Lila, et al. · Rheumatology Science and Practice · 5
PDF
Results of 4 years of therapy with divozilimab in patients with relapsing multiple sclerosis
2025 · A.N. Boyko, V.M. Alifirova, et al. · S S Korsakov Journal of Neurology and Psychiatry · 4
Fri0114 Efficacy of Levilimab, Novel Monoclonal Anti-il-6 Receptor Antibody, in Combination With Methotrexate in Patients With Rheumatoid Arthritis: 1-year Results of Phase 2 Aurora Study
2020 · V. Mazurov, E. Zotkin, et al. · Annals of the Rheumatic Diseases · 4
PDF
Efficacy and safety of a new original interleukin 17A inhibitor in the treatment of patients with active ankylosing spondylitis: results of a basic (BCD-085-3/AILAS) and extended (BCD-085-3ext/AILAS-II) phase II clinical trial
2019 · Sh. Erdes, V. I. Mazurov, et al. · Rheumatology Science and Practice · 4
PDF
Divozilimab reduces the risk of exacerbations in patients with neuromyelitis optica spectrum disorders
2025 · A. N. Boyko, M. N. Zakharova, et al. · Neurology neuropsychiatry Psychosomatics · 3
PDF
The Efficacy and Safety of Divozilimab in Patient with Systemic Sclerosis: 48-Week Results of the Randomized Double-Blind Placebo-Controlled Phase III Clinical Study LIBERIUS
2025 · L. P. Ananyeva, M. N. Starovoytova, et al. · Doklady Biochemistry and Biophysics · 3
PDF
Op0142 Netakimab Reduces Ankylosing Spondylitis Activity in Patients With or Without Sacroiliits on Mri: Results of Subanalysis of Phase 3 Astera Trial
2021 · I. Gaydukova, V. Mazurov, et al. · Annals of the Rheumatic Diseases · 3
Comparative Evaluation of the Long-term Efficacy and Safety of the Infliximab Biosimilar Bcd-055 and Reference Infliximab in Patients With Ankylosing Spondylitis: Results of the International Multicenter Randomized Double-blind Phase Iii Clinical Study Asart-2
2018 · A. M. Lila, V. I. Mazurov, et al. · Rheumatology Science and Practice · 3
Interaction of Transcription Factors Pax-5 and Stat6 in Pathogenesis of Allergic Bronchial Asthma
2014 · V. N. Mineev, L. N. Sorokina, et al. · Medical Immunology (Russia) · 3
PDF
Netakimab in anti-tnF-naïve patients with psoriatic arthritis: subanalysis of patEra clinical trial
2020 · Tatiana V. Korotaeva, Aleksei V. Samtsov, et al. · Consilium Medicum · 2
Transcriptional Fa Ctors Foxp3, Gata-3, Pax-5 and Their Cooperat Ive Interactions in Bronchial Asthma
2014 · V. N. Mineev, L. N. Sorokina, et al. · Medical Immunology (Russia) · 2
PDF
The impact of clinical and demographic factors on the efficacy of divozilimab in patients with systemic sclerosis: Post hoc analysis of the randomized, double-blind, placebo-controlled phase III clinical trial LIBERIUS
2025 · L. P. Ananyeva, A. M. Lila, et al. · Rheumatology Science and Practice · 1
PDF
Levilimab clinical efficacy for interleukin-6 receptor inhibition in COVID-19 and its potential for treating cytokine release syndrome of other aetiologies
2022 · N. V. Lomakin, B. A. Bakirov, et al. · Biological Products Prevention Diagnosis Treatment · 1
PDF
The crucial role of the expression of negative regulator of gene transcription SOCS5 in asthma pathogenesis
2013 · Lada Sorokina, Valeriy Mineev, et al. · European Respiratory Journal · 1
Efficacy and safety of four-year divozilimab treatment in relapsing multiple sclerosis (RMS)
2026 · Aleksey Boyko, Olga Boyko, et al. · Multiple Sclerosis and Related Disorders
Efficacy and Safety of Netakimab in Children and Adolescents with Moderate-to-Severe Plaque Psoriasis: Results of the Core Treatment Period (12 Weeks) of the Randomized Placebo-Controlled Phase III Clinical Trial BCD-085-16/PLANETA-KIDS
2026 · Nikolay N. Murashkin, Andrey L. Bakulev, et al. · Вопросы современной педиатрии
PDF
P.261 The efficacy and safety of divozilimab, anti-CD20 monoclonal antibody in patients with systemic sclerosis
2026 · Lidia Ananyeva, Liudmila Garzanova, et al. · Poster presentations
Efficacy of divozilimab in the treatment of systemic sclerosis: results of the randomized phase III clinical trial BCD-132-5/LIBERIUS
2025 · L. P. Ananyeva, M. N. Starovoytova, et al. · Modern Rheumatology Journal
PDF
Pos0649 Efficacy and Safety of Levilimab in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis: 1-year Results of Phase Iii, Double-blind, Placebo-controlled, Randomized Trial
2022 · V. Mazurov, M. Korolev, et al. · Annals of the Rheumatic Diseases
PDF
Works count: 38
Citation count: 153
H-index: 6
I10-index: 4
Year
Topic
Type